Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene

Abstract

To reverse multidrug resistance (MDR) of HepG2 by anti-MDR1 hammerhead ribozyme, an anti-MDR1 hammerhead ribozyme was developed and delivered to P-gp-overproducing human hepatocarcinoma cell line HepG2 by a retroviral vector containing RNA polymerase III promoter. The expression of mdr1/Pgp and Rz was detected in HepG2, HepG2 multidrug-resistant cell line and HepG2 Rz-transfected cells by semi-quantitative RT-PCR and Western blot methods. Moreover, MTT assay was employed to detect the sensitivity of these ribozyme-transfected cells, and Rhodamine 123 (Rh123) was used to test the function of Pgp. The Rz-transfected HepG2 cells became doxorubicin-sensitive, which was concomitant with the decreased MDR1 expression. The study showed that the retrovirus vector encoding the anti-MDR1 ribozyme may be applicable to the treatment of MDR cells.

Keywords

liver neoplasms / carcinoma / P-glycoprotein / multi-drug resistance / ribozyme

References

[1] KanzakiA, TakebayashiY, RenX Q, et al. . Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743. Mol Cancer Ther, 2002, 1: 1327-1327

[2] DoigeC, SharomM F J. Strategies for the purification of P-glycoprotein from multidrug-resistance Chinese hamster ovary cells. Protein Express Purif, 1991, 2: 256-256

[3] KimS W, KwonH Y, ChiD W, et al. . Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3). Biochem Pharmacol, 2003, 65: 75-75

[4] CarmichaelJ, DeGraffW G, GazdarA F, et al. . Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res, 1987, 47: 936-936

[5] WiechenK, ZimmerC, DietelM. Selection of a high active c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced pure flurescent peotein. Cancer Gene Ther, 1998, 5: 45-45

[6] PhylactouL A. Ribozyme gene therapy. Methods Mol Biol, 2001, 175: 521-521

[7] VolmM, RittgenW. Cellular predictive factors for the drug response of lung cancer. Anticancer Res, 2000, 20: 3449-3449

[8] LiX, SmythA P, BarrettD J, et al. . Sensitization of multidrug-resistant human leukemia cells with MDR1-target antisense and inhibition of drug-mediated MDR1 indution. Leukemia, 1997, 11: 950-950

[9] WarashinaM, KuwabaraT, KatoY, et al. . RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA. Proc Natl Acad Sci USA, 2001, 98: 5572-5572